Opioid Withdrawal Clinical Trials

39 clinical trials for Opioid Withdrawal across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain — RECRUITING · NA
Evaluating Buspirone to Treat Opioid Withdrawal — RECRUITING · PHASE2
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder — RECRUITING
Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder — RECRUITING · NA
CEDRN: Opioid Registry — RECRUITING
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain — RECRUITING · PHASE1
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype — RECRUITING · PHASE2
Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms — RECRUITING · NA
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal — COMPLETED · PHASE1
An Innovative Intervention for OUD Treatment — COMPLETED · PHASE2
Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up — COMPLETED · NA
Sublingual Dexmedetomidine for Treating Opioid Withdrawal — ACTIVE_NOT_RECRUITING · PHASE1
Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids — ACTIVE_NOT_RECRUITING · PHASE2
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD — TERMINATED · PHASE2
A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects — WITHDRAWN · PHASE1
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder — COMPLETED · NA
Suboxone Dispenser for OUD — WITHDRAWN · NA
Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal — TERMINATED · PHASE2
Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal — COMPLETED · PHASE2
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions — COMPLETED
Oral Cannabidiol for Opioid Withdrawal — COMPLETED · PHASE1
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing — OTHER
Opioid Tapering After Spine Surgery — COMPLETED · NA
Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) — WITHDRAWN · NA
Medical Management of Sleep Disturbance During Opioid Tapering — COMPLETED · PHASE2
Open-Label, Safety Study of Lofexidine — COMPLETED · PHASE3
Lofexidine for Adults Undergoing Lumbar Spine Surgery — COMPLETED · PHASE4
Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal — COMPLETED · NA
Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal — COMPLETED · NA
Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction — OTHER · PHASE2
BRIDGE Device for Treatment of Opioid Withdrawal — TERMINATED · NA
Pregabalin for Opiate Withdrawal Syndrome — COMPLETED · PHASE4
Assessing Opioid Care Practices Using CPV Patient Simulation Modules — COMPLETED · NA
Comparison of Three Opioid Detoxification Treatment Regimens — WITHDRAWN · PHASE3
Oxytocin Treatment of Opioid Dependence — COMPLETED · PHASE1
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence — COMPLETED · NA
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal — COMPLETED · PHASE1
Buprenorphine in the Emergency Department — COMPLETED · PHASE4
Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals — COMPLETED · PHASE2

Refine this search